Core Laboratories (CLB) News Today $16.12 -0.75 (-4.42%) Closing price 02/21/2025 03:59 PM EasternExtended Trading$16.14 +0.02 (+0.09%) As of 02/21/2025 04:02 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 Time Period Citigroup Forecasts Strong Price Appreciation for Core Laboratories (NYSE:CLB) StockCitigroup boosted their price target on Core Laboratories from $14.00 to $15.00 and gave the company a "sell" rating in a report on Thursday.February 21 at 1:54 PM | marketbeat.comCore Laboratories price target raised to $15 from $14 at CitiFebruary 20 at 6:12 PM | markets.businessinsider.comThe past five years for Core Laboratories (NYSE:CLB) investors has not been profitableFebruary 20 at 6:12 PM | finance.yahoo.comKornitzer Capital Management Inc. KS Makes New Investment in Core Laboratories Inc. (NYSE:CLB)Kornitzer Capital Management Inc. KS purchased a new position in Core Laboratories Inc. (NYSE:CLB - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund purchased 35,515 shares of the oil and gas company'sFebruary 20 at 4:19 AM | marketbeat.comRice Hall James & Associates LLC Makes New $1.96 Million Investment in Core Laboratories Inc. (NYSE:CLB)Rice Hall James & Associates LLC acquired a new position in Core Laboratories Inc. (NYSE:CLB - Free Report) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 113,203 shares of the oil and gaFebruary 19 at 5:30 AM | marketbeat.comVan ECK Associates Corp Boosts Stock Holdings in Core Laboratories Inc. (NYSE:CLB)Van ECK Associates Corp grew its position in shares of Core Laboratories Inc. (NYSE:CLB - Free Report) by 6.3% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 443,621 shares of the oil and gas company's stock after acqFebruary 18, 2025 | marketbeat.comStifel Nicolaus Remains a Hold on Core Laboratories (CLB)February 12, 2025 | markets.businessinsider.comAre Options Traders Betting on a Big Move in Core Laboratories (CLB) Stock?February 5, 2025 | msn.comBoston Trust Walden Corp Raises Stake in Core Laboratories Inc. (NYSE:CLB)Boston Trust Walden Corp increased its holdings in shares of Core Laboratories Inc. (NYSE:CLB - Free Report) by 2.7% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 617,336 shares of the oil and gas company's stock afFebruary 4, 2025 | marketbeat.comSG Americas Securities LLC Reduces Position in Core Laboratories Inc. (NYSE:CLB)SG Americas Securities LLC lessened its holdings in shares of Core Laboratories Inc. (NYSE:CLB - Free Report) by 66.0% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 23,723 shares of the oil and gas company's stock afterFebruary 3, 2025 | marketbeat.comCore Laboratories Full Year 2024 Earnings: EPS Misses ExpectationsJanuary 31, 2025 | finance.yahoo.comCore Laboratories Inc (CLB) Q4 2024 Earnings Call Highlights: Navigating Challenges with ...January 31, 2025 | gurufocus.comQ4 2024 Core Laboratories Inc Earnings Call TranscriptJanuary 31, 2025 | gurufocus.comCore Laboratories reports Q4 adjusted EPS 22c, consensus 22cJanuary 30, 2025 | markets.businessinsider.comCore Laboratories NV Profit Rises In Q4, But Misses EstimatesJanuary 30, 2025 | markets.businessinsider.comCore Laboratories (CLB) Q4 2024 Earnings Call TranscriptJanuary 30, 2025 | msn.comCore Laboratories targets mid-single-digit growth in reservoir description for 2025 amid headwindsJanuary 30, 2025 | msn.comCore Laboratories Inc. (NYSE:CLB) Announces $0.01 Quarterly DividendCore Laboratories Inc. (NYSE:CLB) declared a quarterly dividend on Thursday, January 30th. Shareholders of record on Monday, February 10th will be given a dividend of 0.01 per share by the oil and gas company on Monday, March 3rd. This represents a $0.04 dividend on an annualized basis and a yield of 0.23%. The ex-dividend date of this dividend is Monday, February 10th.January 30, 2025 | marketbeat.comCore Laboratories (NYSE:CLB) Shares Gap Down - Here's WhyCore Laboratories (NYSE:CLB) Shares Gap Down - Here's WhyJanuary 30, 2025 | marketbeat.comCore Laboratories Inc Reports Q4 EPS of $0.15 and Revenue of $129.2 Million, Missing EstimatesJanuary 29, 2025 | gurufocus.comCore Laboratories (NYSE:CLB) Posts Quarterly Earnings Results, Hits ExpectationsCore Laboratories (NYSE:CLB - Get Free Report) issued its quarterly earnings data on Wednesday. The oil and gas company reported $0.23 earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of $0.23. Core Laboratories had a return on equity of 15.84% and a net margin of 5.83%.January 29, 2025 | marketbeat.comCore Laboratories (NYSE:CLB) Releases Q1 2025 Earnings GuidanceCore Laboratories (NYSE:CLB) updated its first quarter 2025 earnings guidance. The company provided EPS guidance of 0.120-0.160 for the period, compared to the consensus estimate of 0.210. The company also issued revenue guidance of $121.0 millionillion-$127.0 millionillion, compared to the consensus estimate of $131.7 millionillion.January 29, 2025 | marketbeat.comCore Labs Reports Revenue Growth Amid ChallengesJanuary 29, 2025 | tipranks.comCore Laboratories Q4 2024 Earnings PreviewJanuary 28, 2025 | msn.comCore Laboratories (CLB) to Release Earnings on WednesdayCore Laboratories (NYSE:CLB) will be releasing earnings after the market closes on Wednesday, January 29, Financial Modeling Prep reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=218718)January 22, 2025 | marketbeat.comZacks Research Analysts Lower Earnings Estimates for CLBCore Laboratories Inc. (NYSE:CLB - Free Report) - Research analysts at Zacks Research cut their Q3 2025 EPS estimates for shares of Core Laboratories in a research report issued to clients and investors on Friday, January 17th. Zacks Research analyst T. Saha now forecasts that the oil and gas comJanuary 20, 2025 | marketbeat.comShort Interest in Core Laboratories Inc. (NYSE:CLB) Declines By 6.5%Core Laboratories Inc. (NYSE:CLB - Get Free Report) saw a large decrease in short interest during the month of December. As of December 31st, there was short interest totalling 6,290,000 shares, a decrease of 6.5% from the December 15th total of 6,730,000 shares. Currently, 13.5% of the company's shares are sold short. Based on an average trading volume of 309,800 shares, the days-to-cover ratio is currently 20.3 days.January 19, 2025 | marketbeat.comCore Laboratories (CLB) Gets a Hold from Stifel NicolausJanuary 16, 2025 | markets.businessinsider.comBarclays PLC Buys 62,042 Shares of Core Laboratories Inc. (NYSE:CLB)Barclays PLC boosted its stake in shares of Core Laboratories Inc. (NYSE:CLB - Free Report) by 288.2% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 83,570 shares of the oil and gas company's stockJanuary 13, 2025 | marketbeat.comCORE LABORATORIES ANNOUNCES TIMING OF FOURTH QUARTER 2024 EARNINGS RELEASE AND CONFERENCE CALLJanuary 3, 2025 | finance.yahoo.comBarclays PLC Purchases 62,042 Shares of Core Laboratories Inc. (NYSE:CLB)Barclays PLC grew its position in shares of Core Laboratories Inc. (NYSE:CLB - Free Report) by 288.2% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 83,570 shares of the oil and gas company's stock aDecember 29, 2024 | marketbeat.comCore Laboratories (NYSE:CLB) Stock, Guidance And ForecastDecember 23, 2024 | benzinga.comState Street Corp Has $36.60 Million Stock Position in Core Laboratories Inc. (NYSE:CLB)State Street Corp grew its holdings in Core Laboratories Inc. (NYSE:CLB - Free Report) by 2.9% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,975,016 shares of the oil and gas company's stock after purchasing anDecember 21, 2024 | marketbeat.comCore Laboratories (NYSE:CLB) Trading Down 2.6% - Time to Sell?Core Laboratories (NYSE:CLB) Trading Down 2.6% - Should You Sell?December 20, 2024 | marketbeat.comClinical Chemistry and Immunoassay Industry Forecast Report to 2028: Integrated and Scalable Core Lab Solutions Driving Transformational GrowthDecember 17, 2024 | globenewswire.comCore Laboratories Inc. (NYSE:CLB) Short Interest UpdateCore Laboratories Inc. (NYSE:CLB - Get Free Report) saw a large decline in short interest in November. As of November 30th, there was short interest totalling 6,500,000 shares, a decline of 5.1% from the November 15th total of 6,850,000 shares. Approximately 14.0% of the shares of the stock are short sold. Based on an average daily volume of 309,300 shares, the short-interest ratio is presently 21.0 days.December 17, 2024 | marketbeat.comCore Laboratories Inc. (NYSE:CLB) Stock Position Increased by Disciplined Growth Investors Inc. MNDisciplined Growth Investors Inc. MN increased its position in Core Laboratories Inc. (NYSE:CLB - Free Report) by 26.7% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 5,653,591 shares of the oil and gas cDecember 10, 2024 | marketbeat.com53,799 Shares in Core Laboratories Inc. (NYSE:CLB) Acquired by Captrust Financial AdvisorsCaptrust Financial Advisors bought a new stake in shares of Core Laboratories Inc. (NYSE:CLB - Free Report) in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor bought 53,799 shares of the oil and gas company's stocDecember 10, 2024 | marketbeat.comCharles Schwab Investment Management Inc. Reduces Stake in Core Laboratories Inc. (NYSE:CLB)Charles Schwab Investment Management Inc. lowered its position in shares of Core Laboratories Inc. (NYSE:CLB - Free Report) by 11.7% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 529,522December 10, 2024 | marketbeat.comCore Laboratories (NYSE:CLB) Stock Price Down 4% - Should You Sell?Core Laboratories (NYSE:CLB) Stock Price Down 4% - Here's What HappenedDecember 6, 2024 | marketbeat.comZacks Research Has Pessimistic Outlook of CLB Q4 EarningsCore Laboratories Inc. (NYSE:CLB - Free Report) - Research analysts at Zacks Research cut their Q4 2024 EPS estimates for shares of Core Laboratories in a research report issued to clients and investors on Wednesday, December 4th. Zacks Research analyst T. Saha now forecasts that the oil and gasDecember 6, 2024 | marketbeat.comIs Core Laboratories Inc.'s (NYSE:CLB) Recent Stock Performance Influenced By Its Fundamentals In Any Way?December 5, 2024 | finance.yahoo.comPEAK6 Investments LLC Sells 39,910 Shares of Core Laboratories Inc. (NYSE:CLB)PEAK6 Investments LLC decreased its position in shares of Core Laboratories Inc. (NYSE:CLB - Free Report) by 65.8% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 20,750 shares of the oil and gas company's stocDecember 5, 2024 | marketbeat.comFisher Asset Management LLC Grows Stake in Core Laboratories Inc. (NYSE:CLB)Fisher Asset Management LLC boosted its holdings in shares of Core Laboratories Inc. (NYSE:CLB - Free Report) by 19.5% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 990,267 shares of the oil and gas company's stock after purcNovember 28, 2024 | marketbeat.com190,546 Shares in Core Laboratories Inc. (NYSE:CLB) Acquired by Eagle Asset Management Inc.Eagle Asset Management Inc. purchased a new position in shares of Core Laboratories Inc. (NYSE:CLB - Free Report) during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 190,546 shares of the oil and gasNovember 26, 2024 | marketbeat.comRoyce & Associates LP Boosts Stock Holdings in Core Laboratories Inc. (NYSE:CLB)Royce & Associates LP raised its holdings in Core Laboratories Inc. (NYSE:CLB - Free Report) by 9.0% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,021,121 shares of the oil and gas company's stockNovember 16, 2024 | marketbeat.comVan ECK Associates Corp Has $7.13 Million Holdings in Core Laboratories Inc. (NYSE:CLB)Van ECK Associates Corp decreased its holdings in shares of Core Laboratories Inc. (NYSE:CLB - Free Report) by 22.7% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 417,384 shares of the oil and gas companyNovember 8, 2024 | marketbeat.comCore Laboratories (NYSE:CLB) Upgraded to Hold at StockNews.comStockNews.com upgraded shares of Core Laboratories from a "sell" rating to a "hold" rating in a report on Thursday.November 7, 2024 | marketbeat.comCore Laboratories (NYSE:CLB) Upgraded by StockNews.com to HoldStockNews.com upgraded shares of Core Laboratories from a "sell" rating to a "hold" rating in a research report on Monday.October 28, 2024 | marketbeat.comBoston Trust Walden Corp Sells 128,927 Shares of Core Laboratories Inc. (NYSE:CLB)Boston Trust Walden Corp lessened its stake in Core Laboratories Inc. (NYSE:CLB - Free Report) by 17.7% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 600,833 shares of the oil and gas company's stock after selling 128,927 sOctober 27, 2024 | marketbeat.com Get Core Laboratories News Delivered to You Automatically Sign up to receive the latest news and ratings for CLB and its competitors with MarketBeat's FREE daily newsletter. Email Address CLB Media Mentions By Week CLB Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CLB News Sentiment▼1.080.78▲Average Oils/Energy News Sentiment CLB News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CLB Articles This Week▼73▲CLB Articles Average Week Get Core Laboratories News Delivered to You Automatically Sign up to receive the latest news and ratings for CLB and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies VRN News BSM News VAL News RIG News LBRT News SSL News SOC News BKV News HPK News TALO News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:CLB) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | Sponsored[RFK Jr CONFIRMED] Here’s why Dems are TERRIFIEDRobert F. Kennedy Jr was just confirmed as Trump’s secretary of Health and Human Services… but it was NOT easy...NewMarket Health Publishing, LLC. | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredWhat is this southern state hiding?The financial press had a field day this week after President Donald Trump and Department of Government Effici...Stansberry Research | SponsoredElon Takes Aim at Social SecurityElon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredNvidia’s Next Big Move Comes on Feb. 26Nvidia isn't the only company that benefits greatly from these earnings calls. That's because a handful of ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Core Laboratories Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Core Laboratories With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
